Publications
176
Citations
2,562
Est. group size
—
Recurring co-author estimate
Active years
49
Publishing since 1978
Carla S. Fisher is a breast surgical oncology researcher who studies treatments for breast cancer, including surgical approaches, less-invasive options like cryoablation (destroying tumors with cold), and immune-based therapies such as vaccines for HER2-positive breast cancer. Her work also includes computational modeling of how the breast heals and changes shape after breast-conserving surgery, and studies on surgical training and patient care. Her research combines clinical trials, predictive modeling, and medical education.
Publication activity has been steady with notable peaks in 2023 and 2025, averaging about 16 publications per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Directing a Fellowship
2026
- Computational Modeling of Patient-Specific Healing and Deformation Outcomes Following Breast-Conserving Surgery Based on MRI Data
Annals of Biomedical Engineering · 2025
- ASO Visual Abstract: Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants and Program Directors’ Preferences Regarding In-Person Versus Virtual Interviews
Annals of Surgical Oncology · 2025
- Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants’ and Program Directors’ Preferences Regarding In-Person Versus Virtual Interviews
Annals of Surgical Oncology · 2025
- Computational modeling of patient-specific healing and deformation outcomes following breast-conserving surgery based on MRI data
medRxiv · 2025
- Inflammatory Breast Cancer
2025
- ASO Visual Abstract: Cryoablation without Excision for Early Stage Breast Cancer; ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence
Annals of Surgical Oncology · 2024
- Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence
Annals of Surgical Oncology · 2024
- ASO Visual Abstract: External Validation of the Breast Cancer Surgery Risk Calculator (BCSRc): A Predictive Model for Postoperative Complications
Annals of Surgical Oncology · 2023
- Supplemental Figure 4 from Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design Trial
2023
- Supplemental Figure 2 from Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design Trial
2023
- Supplemental Table 2 from Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design Trial
2023
- Supplemental Table 1 from Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design Trial
2023
- Data from Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design Trial
2023
- Data from Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design Trial
2023
- Annals of Surgical Oncology×31
- Plastic & Reconstructive Surgery Global Open×11
- Journal of the American College of Surgeons×9
- Journal of Plastic Reconstructive & Aesthetic Surgery×5
- Journal of Reconstructive Microsurgery×5
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile